This is a synthetic example using fictional company data. It shows the structure, evidence depth, and decision support a client-facing scorecard is designed to provide.
47% of opportunities had close dates pushed two or more times with no stage progression or documented buyer action. The pattern holds across all deal sizes and all six reps reviewed. It adds false confidence to the committed forecast: deals appear active, but buyer momentum is not recorded anywhere.
58% of closed-lost deals carry “Other” or a blank as the loss reason. Win/loss pattern recognition is impossible at this data quality level. Pipeline health scoring, rep coaching by loss pattern, and ICP refinement all require reliable loss categorization. Currently, Northmark cannot answer the question: what do we most commonly lose to, and why?
Stage 4+ deals with no logged meeting, email reply, or documented next step in the past 21 days represent $1.4M in pipeline. These deals appear in the submitted forecast but carry no evidence of active buyer engagement. In 42 structured deal inspections, this pattern correlated with non-conversion in 89% of historical cases at a similar stage.
61% of new pipeline was created in the final three weeks of Q2 2025. This pattern is consistent across all six quarters analyzed. Pipeline created under end-of-quarter pressure to hit coverage ratios has a historically lower conversion rate and longer sales cycle. It also distorts the following quarter’s forecast, since the pipeline count looks healthy but the vintage quality is lower.
In four of six quarters, the final-week forecast submission changed by more than 18% from the prior week’s number. The pattern shows deal advocacy overriding data review: managers accept rep positions instead of examining deal evidence. Fixing it requires a documented inspection protocol run before final numbers are locked, with defined criteria for what qualifies as Commit versus Best Case.
Each finding above names a symptom. The traces below name the cause. Process controls fix the symptom. Only root cause remediation changes the behavior.
The roadmap above covers process controls: field enforcement, inspection cadences, and escalation gates. Controls reduce the opportunity for bad behavior. They do not replace the training that changes it. The three areas below sit with sales leadership to design and deliver. MxM can advise on structure; execution is internal.
Close-date slippage is a symptom of reps setting dates without a buyer-confirmed compelling event. A refresher on what a compelling event is, how to qualify one, and what it takes to commit a close date addresses the root behavior. The CRM gate (no date push without a documented next step) creates friction. Training gives reps a reason to not need the gate.
Field enforcement without explanation produces workarounds. HubSpot allows custom help text on required fields. For the five Stage 4+ required fields, each tooltip should define what good looks like. For example: "Economic buyer: name, title, and date of last direct contact. Not 'CFO' or 'finance team'." Reps who understand why a field matters fill it accurately. Reps who see a mandatory field find the shortest path past it.
The inspection protocol only works if managers know how to run it. Right now, deal reviews function as advocacy sessions: reps present, managers respond. A focused session on evidence-based inspection covers what questions to ask, how to handle missing evidence, and how to move a deal to a lower forecast category without damaging rep confidence. Without this, the formal cadence becomes performative.
MxM can design and deliver a single focused training session built from the behaviors found in this diagnostic. Not a generic sales training. It uses the deal data, the specific slippage patterns, and the actual CRM records reviewed to build a session the team cannot dismiss as theoretical. Available after the control infrastructure is in place. Priced separately from the standard engagement.
No PII required · No API access · CSV exports only